Purchase Order 75F40123P00207
Award Date 6/27/23
Potential Completion Date 6/26/24
Potential Value $105K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02210, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $354,235 purchase order to Emulate Inc., doing business as Emulate, located in Boston, Massachusetts. The firm fixed price contract is for a Liver Human Emulation System to support the FDA's regulatory review processes. Per the original solicitation, the agency sought to procure a Liver-Chip, Quad-Culture Kits, Zoe Culture Modules, an Orb Hub Module and associated equipment with a simple user interface and small...
- The Food and Drug Administration awarded a $248,000 firm fixed price purchase order to Emulate Inc. for Emulate Chip-S1 Basic Research Kits on September 19, 2025. The contract, with an ultimate completion date of September 18, 2026, will be performed at the FDA's Silver Spring, Maryland location. No set-aside designation was applied to this procurement. Emulate Inc., headquartered in Boston, Massachusetts, is a biotechnology company specializing in organ-on-chip microphysiological systems that...
- The Food and Drug Administration awarded a $31,950 purchase order to Emulate Inc. on June 18, 2025, for twelve Chip-R1 Rigid Chip basic research kits under a total small business set-aside designation. The contract, which extends to October 16, 2025, represents a firm fixed price procurement of the company's organ-on-chip technology. Emulate Inc., headquartered in Boston, Massachusetts, specializes in microphysiological systems that replicate human organ functions to support advanced...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Emulate Inc., doing business as Emulate, a for-profit organization. The $200,300.00 contract is for the provision of a human emulation system, which is a set-aside for small businesses. Emulate's organ-on-a-chip technology is designed to model human biology for biomedical research, supporting federal initiatives in areas like personalized medicine, biosurveillance,...
- The Department of Health and Human Services Food and Drug Administration awarded a $149,130 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the delivery of a CDER-2023-117371-ZOE MODULE (ZOE-CM2) WITH AN ORB HUB (ORB-HM1) MCMI23 - ROBUST ORGAN-ON-A-CHIP SYSTEM FOR BIOASSAY DEVELOPMENT. This award responds to Solicitation 75F40123Q00376 which sought a robust organ-on-a-chip system to support the FDA's bioassay development work. Place of performance will be...
- Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip technology, was awarded a $145,260 firm fixed-price purchase order by the Food and Drug Administration on August 1, 2024. The contract calls for delivery of the CHIP-S1 Stretchable Chip (catalog number 10231-2) with an ultimate completion date of August 31, 2024. This award was designated as a Total Small Business set-aside, recognizing Emulate's status as a small business entity. The Food and Drug Administration, a...
- The Food and Drug Administration awarded a purchase order to Emulate Inc. for $45,000 on August 28, 2025, for the procurement of organ-on-chip culture modules, specifically two Emulate Zoe CM1 units and one Orb Hub Module-1. The contract is structured as a firm fixed-price purchase order with an ultimate completion date of August 28, 2026, and performance will take place at the FDA's facility in Silver Spring, Maryland. No set-aside designation was used for this award. Emulate Inc., a...
- The Food and Drug Administration (FDA) awarded a $48,680.00 firm fixed price purchase order to Emulate Inc., a for-profit small business, for the purchase of Emulate Chip-S1 Basic Research Kits. This contract supports the FDA's regulatory science initiatives and advances the agency's work on non-animal testing approaches. The award has an ultimate completion date of August 21, 2025. Emulate Inc. has previously received federal grants, including a cooperative agreement from the Defense Advanced...
- This $164,555.50 firm-fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian government agency, to Emulate Inc., a small business contractor, for the procurement of two Zoe Culture Modules and two Orb Hub Modules of the Human Emulation System. The award, made under a small business set-aside, supports the FDA's regulatory science initiatives and efforts to advance non-animal testing approaches. Emulate Inc. has a long history of providing...
- The Department of Health and Human Services Food and Drug Administration awarded a $213,100 firm fixed price purchase order to Emulate Inc. of Boston, Massachusetts. The contract will provide a human emulation system including an ORB-HM1 hub module, two used ZOE-CM2 culture modules, and one new ZOE-CM2 culture module with a one year warranty. Additionally, a service agreement will cover maintenance of the three used items for one year. Per the sole source solicitation, Emulate will satisfy the...